Filing Flows › Avalo Therapeutics (AVTX) › Who owns the stock
Who owns Avalo Therapeutics (AVTX) stock
121 funds reported Avalo Therapeutics (AVTX) shares in their latest 13F filings, worth $1.3B in all. The largest holder is FMR LLC ($94.3M). Last quarter 79 funds added to their stakes and 56 cut them.
Largest holders (13F)
| Fund | Shares | Value | Change | Quarter |
|---|---|---|---|---|
| FMR LLC | 5,100,216 | $94.3M | increase | 2026-06-30 |
| BlackRock | 4,365,553 | $80.7M | increase | 2026-06-30 |
| Nantahala Capital Management, LLC | 3,724,500 | $68.8M | increase | 2026-06-30 |
| Deep Track Capital, LP | 3,610,000 | $66.7M | new | 2026-06-30 |
| Caligan Partners LP | 3,163,866 | $58.5M | increase | 2026-06-30 |
| TCG Crossover Management, LLC | 3,017,120 | $55.8M | increase | 2026-06-30 |
| Affinity Asset Advisors, LLC | 2,900,000 | $53.6M | increase | 2026-06-30 |
| State Street | 2,889,287 | $53.4M | increase | 2026-06-30 |
| Point72 Asset Management, L.P. | 2,387,026 | $44.1M | increase | 2026-06-30 |
| Avoro Capital Advisors LLC | 2,333,333 | $43.1M | increase | 2026-06-30 |
| Vanguard Capital Management LLC | 2,264,246 | $41.8M | increase | 2026-06-30 |
| BVF | 2,075,545 | $38.4M | increase | 2026-06-30 |
| Bank of America | 1,913,829 | $35.4M | increase | 2026-06-30 |
| Adage Capital Partners GP, L.L.C. | 1,729,000 | $32.0M | increase | 2026-06-30 |
| Soleus Capital Management, L.P. | 1,654,978 | $30.6M | increase | 2026-06-30 |
Avalo Therapeutics' latest quarter
Avalo Therapeutics, Q4 2025: revenue $59K (-69% year over year), net loss $13.7M, operating cash flow −$14.2M. The chart follows the revenue to costs, profit and cash.
Questions
Who owns the most AVTX stock?
By the latest 13F filings: FMR LLC ($94.3M); BlackRock ($80.7M); Nantahala Capital Management, LLC ($68.8M); Deep Track Capital, LP ($66.7M); Caligan Partners LP ($58.5M).
What is the short interest in AVTX?
11,963,625 shares were sold short at the 2026-10-15 settlement, 4.9% of the float.
Updated Nov 8, 2026. Read automatically from SEC filings and public data; errors are possible. Not investment advice.